Nathaniel Amory

Boston
  • 200 Clarendon Street
  • Boston, MA 02116
  • USA
 
 

Nate Amory is a partner in the Corporate Department of Latham & Watkins. Mr. Amory’s practice focuses on representing growth equity firms and private equity sponsors and their portfolio companies, in connection with:

  • Acquisitions, dispositions, recapitalizations, joint ventures, and minority investments   
  • Reorganizations, asset and business division carve-outs, and corporate restructurings
  • General corporate matters

Mr. Amory has significant experience representing founders, investors, and acquirors in public and private acquisition and sale transactions in a variety of industry sectors, including retail, technology, energy, healthcare, telecommunications systems, and infrastructure. 

Mr. Amory’s selected representative matters include representing:

  • WestView Capital Partners in numerous transactions including its acquisition or disposition of or investment in:
    • Wavelink 
    • Apex Technologies
    • Abacus Group
    • Alpha II
    • Davex Labs
    • Mintz Group
    • Park Place Technologies
    • Phia Group
  • ABRY Partners in its acquisition and sale of NSM Insurance Group
  • Spectrum Equity in numerous transactions including its acquisition or disposition of or investment in:
    • Verisys
    • Rain King Software
    • ExactBid
  • Castanea Partners in its majority investment in West Coast Fitness
  • J.W. Childs in its majority investment in Honor Holdings and related acquisitions
  • BV Investments in its acquisition of Precision Nutrition
  • MC Partners in its investment in Neutral Connect and 5 Bars
  • The acquisition by Town & Country Holdings, an H.I.G. Capital portfolio company, of Home Dynamix
  • Falcon Investment Advisors in its investments in each of:
    • Bobcat Disposal
    • Integrity Directional Service
    • Laney Directional Drilling
  • Great Hill Partners in the sale of All Web Leads to Genstar
  • Boathouse Capital in its investments in:
    • CellTrak
    • Mediafly
    • OrthoFi
  • Zipcar in its sale to Avis
  • Network Engines in its sale to UNICOM Systems
  • Micronetics in its sale to Mercury Computer Systems
  • Constant Contact in its acquisition of Cardstar
  • Claros Diagnostics in its sale to Opko Health
  • Aratana Therapeutics in its acquisition of Vet Therapeutics
  • Atrium Medical Corporation in its sale to GETINGE AB
  • Boston Scientific Corporation in various joint venture, licensing supply and distribution arrangements, as well as its acquisitions of:   
    • Electrophysiology Division of C. R. Bard
    • Rhythmia Medical
    • Certain assets of Anulex Technologies
  • Narragansett Brewing Company in its Series D preferred stock financing and related equity arrangements    
  • Numerous life sciences and technology companies in preferred stock financings and related equity arrangements      
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.